Norgine B.V. Completes Important Regulatory Milestone For Angusta® (Misoprostol) In Europe For Oral Induction Of Labour
Amsterdam (ots/PRNewswire) - - Norgine will now seek to extend ANGUSTA®'s licence to a number of European countries - ANGUSTA®'s licence extension for these countries will be subject to national approvals Norgine B.V. (Norgine) today announced the successful completion of the Repeat Use Procedure (RUP) for ...